When the November 2020 news broke that two vaccines had proven to be highly effective in preventing COVID-19 or minimizing its impact, people everywhere began talking about seeing a light at the end of the tunnel. But many public health experts were talking, too, about another bright spot – the vast numbers of participants from racial and ethnic...
When the November 2020 news broke that two vaccines had proven to be highly effective in preventing COVID-19 or minimizing its impact, people everywhere began talking about seeing a light at the end of the tunnel. But many public health experts were talking, too, about another bright spot – the vast numbers of participants from racial and ethnic...
NIH-funded study finds higher dose is not more effective at reducing serious flu complications in this high-risk group High-dose influenza (commonly known as flu) vaccines are no better than regular-dose influenza vaccines in reducing deaths and hospitalizations among patients with underlying heart disease, according to a large study publishing in...
Updates to six key areas of asthma care focus on improving diagnosis, management and treatment The National Institutes of Health today announced 19 recommendations in six key areas of asthma diagnosis, management and treatment. The new guidance, published in the Journal of Allergy and Clinical Immunology , represents the first updates to federal...
WHAT: The National Heart, Lung, and Blood Institute (NHLBI) announces selection of Director of the National Center on Sleep Disorders Research (NCSDR). Congress established the NCSDR in 1993 to coordinate sleep research throughout NIH and other federal agencies. Dr. Brown succeeds Michael Twery, Ph.D., who served as the NCSDR director since 2006...
Using a life support machine to replicate the functions of the heart and lungs significantly improved the survival of people who suffered from out-of-hospital cardiac arrest, according to a new study published today in The Lancet . The treatment program involving the life support machine called extracorporeal membrane oxygenation (ECMO) proved so...
A National Institutes of Health clinical trial evaluating the safety and effectiveness of hydroxychloroquine for the treatment of adults with coronavirus disease 2019 (COVID-19) has formally concluded that the drug provides no clinical benefit to hospitalized patients. Though found not to cause harm, early findings in June when the trial was...
Targeting cell’s ‘trash compactor’ could lead to new antiviral strategy to fight COVID-19 Researchers at the National Institutes of Health have discovered a biological pathway that the novel coronavirus appears to use to hijack and exit cells as it spreads through the body. A better understanding of this important pathway may provide vital insight...
Los Institutos Nacionales de Salud (NIH, por sus siglas en inglés) anunciaron hoy una subvención de $12 millones para proyectos de promoción de salud y participación comunitaria en regiones con minorías étnicas y raciales afectadas de manera desproporcionada por la pandemia de COVID-19. Con estos fondos, RTI International, una institución de...
The National Institutes of Health today announced a $12 million award for outreach and engagement efforts in ethnic and racial minority communities disproportionately affected by the COVID-19 pandemic. The award to RTI International, a non-profit research institution, will support teams in 11 states established as part of the NIH Community...
The National Institutes of Health has launched two of three adaptive Phase 3 clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19. Part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, these trials will be conducted at more than 100...